Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml
Synlett 2023; 34(13): 1631-1633
DOI: 10.1055/a-2017-4176
DOI: 10.1055/a-2017-4176
letter
Formamidine-Induced Translocative Rearrangement of 2-Pyrones to 2-Pyridone Analogues with a 1,5-Diketo Motif
The authors acknowledge SERB, Delhi, for financial support (EMR/2017/003331)
Abstract
A new formamidine-induced translocative rearrangement of 2-pyrone analogues into 2-pyridone derivatives with a 1,5-diketo motif was identified. All the products were characterized by spectroscopic analysis. In addition, single-crystal X-ray structural studies of two molecules were performed.
Key words
ring transformation - rearrangement - pyrones - pyridones - diketones - medicinal chemistrySupporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/a-2017-4176. Included are the experiment procedure and characterization data of final compounds.
- Supporting Information
Publication History
Received: 26 November 2022
Accepted after revision: 21 January 2023
Accepted Manuscript online:
21 January 2023
Article published online:
14 March 2023
© 2023. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References and Notes
- 1 Sangwan S, Yadav N, Kumar R, Chauhan S, Dhanda V, Walia P, Duhan A. Eur. J. Med. Chem. 2022; 232: 114199
- 2 Lin S, Liu C, Zhao X, Han X, Li X, Ye Y, Li Z. Front. Chem. 2022; 10: 869860
- 3 Mahía A, Peña-Díaz S, Navarro S, Galano-Frutos JJ, Pallarés I, Pujols J, Díaz-de-Villegas MD, Gálvez JA, Ventura S, Sancho J. Bioorg. Chem. 2021; 117: 105472
- 4 Wang Y, Gu S.-X, He Q, Fan R. Eur. J. Med. Chem. 2021; 225: 113787
- 5 Leone D.-L, Hubálek M, Pohl R, Sýkorová V, Hocek M. Angew. Chem. Int. Ed. 2021; 60: 17383
- 6 Podyachev SN, Zairov RR, Mustafina AR. Molecules 2021; 26: 1214
- 7 Hirano K, Miura M. Chem. Sci. 2018; 9: 22
- 8 Ghosez L, Jnoff E, Bayard P, Sainte F, Beaudegnies R. Tetrahedron 1999; 55: 3387
- 9 Brun EM, Gil S, Mestres R, Parra M. Synthesis 2000; 273
- 10 Takaoka K, Aoyama T, Shioiri T. Tetrahedron Lett. 1996; 37: 4973
- 11 Dobler D, Leitner M, Moor N, Reiser O. Eur. J. Org. Chem. 2021; 6180
- 12 Hosmane RS, Bakthavachalam V, Leonard NJ. J. Am. Chem. Soc. 1982; 104: 235
- 13 Konreddy AK, Toyama M, Ito W, Bal C, Baba M, Sharon A. ACS Med. Chem. Lett. 2014; 5: 259
- 14 CCDC 2178512 and 2178513 contain the supplementary crystallographic data for compounds 2c and 2g, respectively. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures.
- 15a Sheldrick GM. Acta Crystallogr., Sect. C: Struct. Chem. 2015; 71: 3
- 15b Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JA. K, Puschmann H. J. Appl. Crystallogr. 2009; 42: 339
- 16 Compounds 2a–g; General Procedure Formamidine acetate (0.45 g, 4.35 mmol) and KOH (0.83 g, 14.5 mmol) were dissolved in anhyd DMF, and the resulting mixture was stirred for 10–15 min under N2. The appropriate pyrancarboxamide 1a–g (1 g, 2.9 mmol) was added and the resulting mixture was stirred at rt for 6–8 h. When the reaction was complete [TLC; Rf = 0.5 (30% EtOAc–hexane)], the mixture was poured into ice-cooled water and the precipitate was collected by filtration. The filtrate, which contained some product, was extracted with EtOAc (3 × 20 mL), and the organic layer was dried (Na2SO4) and concentrated under reduced pressure. The precipitate and the extracted crude from the organic layer were combined and then purified by column chromatography (silica gel, EtOAc–hexane). 5-Benzoyl-4-(methylsulfanyl)-2-oxo-N-phenyl-1,2-dihydropyridine-3-carboxamide (2a) White powder; yield: 70%; mp 235–238 ℃; IR (KBr): 1658 (C=O), 3089 (NH) cm–1. 1H NMR (400 MHz, DMSO-d 6): δ = 2.19 (s, 3 H, SMe), 7.02–7.06 (m, 1 H, ArH), 7.28–7.32 (m, 2 H, ArH), 7.51–7.56 (m, 3 H, ArH), 7.62–7.67 (m, 3 H, ArH), 7.76–7.78 (m, 2 H, ArH), 10.42 (s, 1 H, NH), 12.32 (s, 1 H, NH). 13C NMR (100 MHz, DMSO-d 6): δ = 18.0, 119.5, 120.1, 124.9, 129.4, 129.5, 129.9, 130.2, 134.5, 137.0, 138.5, 139.2, 150.2, 159.6, 163.9, 193.5. HRMS (ESI): m/z [M + H]+ calcd for C20H17N2O3S: 365.0954; found: 365.0933. 5-Benzoyl-N-(3-methylphenyl)-4-(methylsulfanyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (2b) Yellow powder; yield: 75%; mp 165–167 ℃. IR (KBr): 1666 (C=O), 3332 (NH) cm–1. 1H NMR (400 MHz, DMSO-d 6): δ = 2.19 (s, 3 H, SMe); 2.25 (s, 3 H, Me); 6.85–6.87, (m, 1 H, ArH); 7.15–7.19 (m, 1 H, ArH); 7.39–7.41 (m, 1 H, ArH); 7.49–7.56 (m, 4 H, ArH); 7.63–7.67 (m, 1 H, ArH); 7.76–7.78 (m, 2 H, ArH), 10.36 (s, 1 H, NH); 12.32 (s, 1 H, NH). 13C NMR (100 MHz, DMSO-d 6): δ = 18.2, 21.7, 116.8, 120.1, 124.7, 129.3, 129.9, 130.1, 133.9, 137.7, 138.5, 139.0, 139.5, 148.8, 159.4, 163.4, 192.6. HRMS (ESI): m/z [M + H]+ calcd for C21H19N2O3S: 379.1111; found: 379.1085.